P

Inventor

YANG MICHAEL G

US43 patents
⚠️ This page may combine multiple inventors who share the name “YANG MICHAEL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

27 patents
US7163937B2Jan 16, 2007

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO29 citations92
US7001901B2Feb 21, 2006

Tetrazolylpropionamides as inhibitors of Aβ protein production

BRISTOL MYERS SQUIBB CO23 citations92
US11021462B2Jun 1, 2021

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

BRISTOL MYERS SQUIBB CO6 citations84
US7378409B2May 27, 2008

Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO20 citations83
US11787779B2Oct 17, 2023

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

BRISTOL MYERS SQUIBB CO2 citations73
US10294256B2May 21, 2019

Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses

BRISTOL MYERS SQUIBB CO5 citations73
US10166249B2Jan 1, 2019

Substituted bicyclic compounds

BRISTOL MYERS SQUIBB CO2 citations73
US7629351B2Dec 8, 2009

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process

BRISTOL MYERS SQUIBB CO5 citations73
US7482335B2Jan 27, 2009

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO6 citations73
US10435369B2Oct 8, 2019

Tricyclic sulfones as ROR gamma modulators

BRISTOL MYERS SQUIBB CO6 citations71
US11767322B2Sep 26, 2023

Triazolopyridinyl compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations70
US7671062B2Mar 2, 2010

Modulators of chemokine receptor activity, crystalline forms and process

BRISTOL MYERS SQUIBB CO4 citations63
US12365667B2Jul 22, 2025

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

BRISTOL MYERS SQUIBB CO0 citations62
US11701373B2Jul 18, 2023

Substituted bicyclic compounds

BRISTOL MYERS SQUIBB CO0 citations62
US11058696B2Jul 13, 2021

Substituted bicyclic compounds

BRISTOL MYERS SQUIBB CO0 citations62
US9522888B2Dec 20, 2016

Substituted bicyclic compounds

BRISTOL MYERS SQUIBB CO2 citations62
US12110290B2Oct 8, 2024

Triazolopyridinyl compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations61
US11597721B2Mar 7, 2023

Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO1 citations59
US10781215B2Sep 22, 2020

Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO0 citations52
US10709719B2Jul 14, 2020

Substituted bicyclic compounds

BRISTOL MYERS SQUIBB CO0 citations52
US10633339B2Apr 28, 2020

Tricyclic sulfone compound as a ROR gamma modulator

BRISTOL MYERS SQUIBB CO0 citations52
US9770459B2Sep 26, 2017

Substituted bicyclic compounds

BRISTOL MYERS SQUIBB CO0 citations52
US7829571B2Nov 9, 2010

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US7687508B2Mar 30, 2010

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US12473290B2Nov 18, 2025

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

BRISTOL MYERS SQUIBB CO0 citations51
US9796720B2Oct 24, 2017

Imidazole-derived modulators of the glucocorticoid receptor

BRISTOL MYERS SQUIBB CO0 citations41
US9593113B2Mar 14, 2017

Imide and acylurea derivatives as modulators of the glucocorticoid receptor

BRISTOL MYERS SQUIBB CO0 citations41

BRISTOL MYERS SQUIBB PHARMA CO

10 patents

ARIAD PHARMA INC

3 patents

DU PONT PHARM CO

2 patents

(unassigned)

1 patent